FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be applied for treatment of liver failure. Transplant for treatment of liver failure includes heterogenic biocompatible biodegradable gel, which has total volume not less than 0.1 ml and the smallest linear size not less than 0.2 mm, pore size 30-500 mcm, total porosity 50-98%, implanted on it autologous progenitor cells of bone marrow after their cultivation in vitro and cultivated autologous liver cells, concentration of liver and bone marrow cells being 2×106-15×106 cells per 1 cm3 of heterogeneous gel and ratio of bone marrow cells to liver cells being from 1:1 to 1:4. In realisation of method of treating liver failure transplant is placed into parenchyma of liver and/or mesentery of small intestine.
EFFECT: group of inventions makes it possible to increase term of cell survival, activate their proliferation.
4 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425646C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
METHOD OF DISTANT HEPATOCYTE REGENERATION STIMULATION | 2015 |
|
RU2590859C1 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
METHOD OF TREATING ACUTE HEPATIC IMPAIRMENT | 2018 |
|
RU2701792C1 |
BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
Authors
Dates
2011-08-10—Published
2010-03-18—Filed